Scinai Immunotherapeutics Ltd. - ADSs (BVXV) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2015 to Q4 2022

Type / Class
Equity / ADSs
Symbol
BVXV
Shares outstanding
592,878
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SABBY MANAGEMENT, LLC 4.9% $26,727 29,051 SABBY MANAGEMENT, LLC 31 Dec 2024

Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q4 0 $0 -$153,000 0
2022 Q3 209,677 $153,000 -$106,277 $0.73 10
2022 Q2 333,325 $388,000 -$10,463 $1.17 12
2022 Q1 326,493 $538,300 -$99,441 $1.66 13
2021 Q4 335,607 $788,000 +$369,454 $2.35 12
2021 Q3 254,692 $560,000 -$195,359 $2.20 15
2021 Q2 311,298 $891,000 -$9,853 $2.86 15
2021 Q1 283,618 $1,077,000 +$263,027 $3.79 17
2020 Q4 220,971 $621,000 -$16,795,390 $2.81 9
2020 Q3 539,390 $21,087,000 +$2,403,450 $39.09 17
2020 Q2 506,304 $11,519,000 +$2,313,777 $22.75 14
2020 Q1 404,429 $3,115,000 -$3,450,073 $7.71 7
2019 Q4 476,756 $4,429,000 +$658,000 $9.24 10
2019 Q3 405,665 $2,410,000 $0 $5.72 7
2019 Q2 405,665 $2,337,000 -$63,080 $5.76 7
2019 Q1 417,334 $2,266,000 -$139,525 $5.43 9
2018 Q4 446,374 $2,129,000 +$105,506 $4.77 10
2018 Q3 448,784 $2,513,000 +$7,534 $5.60 11
2018 Q2 447,247 $2,981,000 -$159,060 $6.67 11
2018 Q1 475,286 $2,580,000 -$49,352 $5.42 13
2017 Q4 486,218 $2,605,000 +$130,260 $5.34 10
2017 Q3 96,181 $687,000 +$555,133 $7.14 7
2017 Q2 18,497 $162,000 -$254,499 $8.67 4
2017 Q1 62,719 $364,000 +$220,999 $5.81 4
2016 Q4 29,000 $101,000 -$13,000 $3.51 2
2016 Q3 32,486 $119,000 -$3,000 $3.67 3
2016 Q2 33,393 $118,000 +$2,000 $3.53 3
2016 Q1 32,793 $122,000 +$3,000 $3.73 3
2015 Q4 32,000 $126,000 -$60,000 $3.94 2
2015 Q3 48,159 $177,000 -$216,090 $3.71 5
2015 Q2 100,047 $495,000 +$495,004 $4.95 5